Patents by Inventor Zhou Songyang

Zhou Songyang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210395812
    Abstract: The present invention provide a method for detecting the genome-wide off-target effects of adenine base editor (ABE) and the application in gene editing thereof. ABE comprises the TadA:TadA*:Cas9 fusion protein and gRNA which is able to catalyze the substitution of A to G with high efficiency at the target site, which can bring ABE a bright application prospect in gene editing and construction of disease model for human disease. Thus, the present invention provides the EndoV-seq method first time to detect the genome-wide off-target effects of ABE. The EndoV-seq method has a wide application prospect in gene editing, especially in gene editing for treatment field of human disease.
    Type: Application
    Filed: September 23, 2019
    Publication date: December 23, 2021
    Inventors: Zhou SONGYANG, Puping LIANG, Junjiu HUANG
  • Publication number: 20030148377
    Abstract: The invention provides methods for rapidly determining kinase binding site motifs using a oriented degenerate peptide library approach. The methods involve the selection of peptides by binding affinity. Inhibitors of kinases that include or compete for the binding site motifs determined using the methods also are provided, as are methods and compositions for using these binding site motifs and inhibitors.
    Type: Application
    Filed: December 14, 2001
    Publication date: August 7, 2003
    Inventors: Kiyotaka Nishikawa, Hung-Sen Lai, Zhou Songyang, Michael B. Yaffe, Lewis C. Cantley
  • Publication number: 20020068301
    Abstract: Methods for determining an optimal binding motif for a binding compound are provided in which the binding compound is contacted with an oriented degenerate cyclic peptide library (ODCPL) under conditions which allow for interaction between the binding compound and the ODCPL such that a complex is formed between the binding compound and a subpopulation of library members capable of interacting with the binding compound. The subpopulation of library members capable of interacting with the binding compound is then separated from library members that are incapable of interacting with the binding compound. The subpopulation of library members capable of interacting with the binding compound is linearized to form a subpopulation of linearized library members.
    Type: Application
    Filed: May 28, 1997
    Publication date: June 6, 2002
    Inventors: HUNG-SEN LAI, MICHAEL B. YAFFE, ZHOU SONGYANG, KERMIT L. CARRAWAY, LEWIS C. CANTLEY
  • Patent number: 6004757
    Abstract: The invention provides a method for determining an amino acid sequence motif for a phosphorylation site of a protein kinase. In the method of the invention, a protein kinase is contacted with an oriented degenerate peptide library, peptides within the library which are substrates for the kinase are converted to phosphopeptides and the phosphopeptides are separated from non-phosphorylated peptides. The isolated phosphopeptides are sequenced and an amino acid sequence motif for the phosphorylation site is determined based upon the relative abundance of different amino acids residues at each degenerate position. The invention also provides peptide substrates for protein kinase A, cell cycle control kinases (including cyclin B/p33.sup.cdc2 and cyclin A/p33.sup.CDK2), src family kinases (including pp60.sup.c-src and pp60.sup.v-src), EGF receptor, p92.sup.
    Type: Grant
    Filed: January 6, 1995
    Date of Patent: December 21, 1999
    Assignee: Beth Israel Hospital
    Inventors: Lewis C. Cantley, Zhou Songyang
  • Patent number: 5532167
    Abstract: The invention provides a method for determining an amino acid sequence motif for a phosphorylation site of a protein kinase. In the method of the invention, a protein kinase is contacted with an oriented degenerate peptide library, peptides within the library which are substrates for the kinase are converted to phosphopeptides and the phosphopeptides are separated from non-phosphorylated peptides. The isolated phosphopeptides are sequenced and an amino acid sequence motif for the phosphorylation site is determined based upon the relative abundance of different amino acids residues at each degenerate position. The invention also provides peptide substrates for protein kinase A, cell cycle control kinases, src family kinases, the EGF receptor and p92.sup.c-fps/fes based upon amino acid sequence motifs for the phosphorylation sites of these kinases.
    Type: Grant
    Filed: January 7, 1994
    Date of Patent: July 2, 1996
    Assignee: Beth Israel Hospital
    Inventors: Lewis C. Cantley, Zhou Songyang